One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Are TNF inhibitors still the agent of choice for RA?
Peter C. TaylorÂÂ
doi : 10.1038/s41584-023-01043-y
Volume 19 Issue 12, December 2023
Maximizing the success of biosimilar implementation
Rieke Alten & Max Weinbrecht-MischkewitzÂ
Dual inhibitor targets fibroblast metabolism in RA
Jessica McHughÂÂ
l-arginine inhibits arthritis and bone loss by reprogramming osteoclast metabolism
Sarah OnuoraÂÂ
25 years of biologic DMARDs in rheumatology
Marc Feldmann, Ravinder N. Maini, Enrique R. Soriano, Vibeke Strand & Tsutomu TakeuchiÂ
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
Hanna W. van Steenbergen, Andrew P. Cope & Annette H. M. van der Helm-van MilÂ
Treatment of systemic juvenile idiopathic arthritis
Claas H. Hinze, Dirk Foell & Christoph KesselÂ
Immune mechanisms of depression in rheumatoid arthritis
James Brock, Neil Basu, Johannes C. M. Schlachetzki, Georg Schett, Iain B. McInnes & Jonathan CavanaghÂ
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Alexander G. S. Oldroyd, Jeffrey P. Callen, Hector Chinoy, Lorinda Chung, David Fiorentino, Patrick Gordon, Pedro M. Machado, Neil McHugh, Albert Selva-O’Callaghan, Jens Schmidt, Sarah L. Tansley, Ruth Ann Vleugels, Victoria P. Werth, International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group & Rohit AggarwalÂ
Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis
Dennis McGonagle, Paula David, Tom Macleod & Abdulla WatadÂ
